
    
      This study is a post-marketing surveillance to monitor safety and efficacy of adefovir
      dipivoxil and identify SAEs, adverse drug reactions (ADRs), and unexpected AEs not described
      as precautions or warnings and to identify possible factors that have an effect on the AEs
      and to assess effectiveness of adefovir dipivoxil in real clinical practices after marketing.
      The subjects are patients prescribed for adefovir dipivoxil by the investigators at the sites
      based on prescription information in normal clinical practices.
    
  